Sales 2025 by Business Segment

Sales 2025 by Geography

Historical Breakdown of Revenue by Business Segments

Operating Income: Breakdown by Business Segment

Breakdown by Business Segment (EUR)
Fiscal Period: December 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Biological Products

          

Biopharma

381.5Cr 500.54Cr 555.83Cr 614.26Cr 648.7Cr

Total Assets

949.92Cr 1.32TCr 1.34TCr 1.43TCr 1.34TCr

CAPEX

-35Cr - - - -

EBITDA

- - - - 174.6Cr

D&A

23Cr 29Cr 33Cr 33Cr 34Cr

Operating Income

66Cr 79Cr 90Cr 127.12Cr 140.1Cr

Bio Supplies

23Cr 15Cr 16Cr 22Cr 15Cr

Total Assets

10Cr 34Cr 38Cr 35Cr 28Cr

CAPEX

-1.38Cr - - - -

EBITDA

- - - - 4.9Cr

D&A

29.48L 57.59L 92.8L 93.05L 90L

Operating Income

4.6Cr 11Cr 4.36Cr 4.78Cr 4Cr

Raw Materials and Others

- - - - -

Total Assets

- - - - -

CAPEX

- - - - -

D&A

- - - - -

Operating Income

- - - - -

Medical Testing, Analyzing, and Diagnostic Equipment

          

Diagnostic

78Cr 67Cr 67Cr 64Cr 64Cr

Total Assets

351.4Cr 368.16Cr 352.89Cr 375.48Cr 338.9Cr

CAPEX

-2Cr - - - -

EBITDA

- - - - 16Cr

D&A

8.86Cr 6.47Cr 6.58Cr 6.45Cr 6.3Cr

Operating Income

15Cr 13Cr 11Cr 11Cr 9.6Cr

Pharmaceutical Contract Manufacturing Services

          

Others

3.96Cr 25Cr 20Cr 21Cr 24Cr

Total Assets

247.25Cr 268.02Cr 266.24Cr 89Cr 86Cr

CAPEX

-1.6Cr - - - -

EBITDA

- - - - -2.6Cr

D&A

69.78L 2.04Cr 1.62Cr 1.57Cr 1.6Cr

Operating Income

-5.86Cr -4.68Cr 66.32L 3.94Cr -4.2Cr

Intersegments

-6.75Cr -89.48L - - -

Total Assets

-4Cr -69.97L - - -

Operating Income

-1.09Cr 3.54Cr 69.79L - -

Operating Income

-19Cr -22Cr -27Cr -28Cr -25Cr

EBITDA

- - - - -24Cr

Total Assets

- - - - 30Cr

Total Assets

341.78Cr 160.85Cr 140.09Cr 211.01Cr 147.1Cr

CAPEX

-5.54Cr - - - -

D&A

2.11Cr 2.29Cr 2.21Cr 2.06Cr 1.7Cr

Pharmaceutical Products

          

Hospital

14Cr - - - -

Total Assets

27Cr - - - -

CAPEX

-1.26Cr - - - -

D&A

1.21Cr - - - -

Operating Income

-77.35L - - - -

Geographical Revenue Distribution History

Geographical breakdown of sales (EUR)
Fiscal Period: December 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

USA and Canada

315.45Cr 385.56Cr 389.9Cr 408.7Cr 425.3Cr

Total Assets

1.05TCr 1.16TCr 1.08TCr 1.18TCr 1.07TCr

CAPEX

-30Cr - - - -

Rest of World

87Cr 117.62Cr 143.71Cr 158.4Cr 165.7Cr

Total Assets

222.29Cr 221.66Cr 223.66Cr 40Cr 46Cr

CAPEX

-97.58L - - - -

Rest of European Union

54Cr 71Cr 89Cr 111.83Cr 119.6Cr

Total Assets

539.34Cr 660.03Cr 705.45Cr 758.43Cr 694.3Cr

CAPEX

-9.14Cr - - - -

Spain

36Cr 32Cr 36Cr 42Cr 42Cr

Total Assets

109.24Cr 115.61Cr 119.06Cr 163.55Cr 163.9Cr

CAPEX

-7.1Cr - - - -

Unallocated Raw Material & Others

- - - - -

Total Assets

- - - - -